The said drug is equivalent to reference listed drug, Adcirca tablets. Tadalafil relaxes muscles of the blood vessels and increases blood flow to particular areas of the body. It is used to treat pulmonary arterial hypertension and improve exercise capacity in men and women.
The drug will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad (India).
According to IQVIA MAT April 2023, Tadalafil tablets USP, 20 mg had annual sales of $61 million in the United States.
As of 31 March 2023, the group now has 369 approvals and has so far filed over 442 ANDAs since the commencement of the filing process in FY 2003-04.
Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.
The company's consolidated net profit (from continuing operations) tumbled 27.55% to Rs 298.8 crore despite of 31.66% jump in total revenue from operations to Rs 5,010.6 crore in Q4 FY23 over Q4 FY22.
The scrip rose 0.18% to currently trade at Rs 515.95 on the BSE.
|